Rate this Article: Risk and Benefits of Canagliflozin, a New Sodium-Glucose Co-Transporter Type 2 Inhibitor, in the Treatment of type-2 Diabetes Mellitus

Rating (1-10):

5

Comments (SUB15416): Full Name: Email Address:

Back to Article